Bacterial biofilms are most problematic where topical treatments (detoll, iodine etc) would be ineffective if applied; BlastX’s primary market is for use during surgery.
It sounds like a product with a lot of promise. Changing surgical behaviours to adopt this product is where the hard work currently is; over time the efficacy of the product should speak for itself.
Charts NXS, page-351
-
- There are more pages in this discussion • 582 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
-0.030(8.82%) |
Mkt cap ! $90.42M |
Open | High | Low | Value | Volume |
32.5¢ | 32.5¢ | 31.0¢ | $70.31K | 222.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 97937 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
33.0¢ | 26000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 97937 | 0.310 |
1 | 25000 | 0.305 |
2 | 5333 | 0.300 |
3 | 17700 | 0.280 |
1 | 11000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.330 | 26000 | 2 |
0.345 | 54296 | 1 |
0.360 | 40000 | 1 |
0.365 | 2739 | 1 |
0.370 | 28075 | 2 |
Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
Last
31.5¢ |
  |
Change
-0.030 ( 5.15 %) |
|||
Open | High | Low | Volume | ||
32.5¢ | 32.5¢ | 31.0¢ | 120300 | ||
Last updated 15.59pm 29/04/2024 ? |
Featured News
NXS (ASX) Chart |